MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 billion by 2014

The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.

Online PR News – 04-May-2010 – – Dallas, TX:- According to a new market research report, ‘global oncology biomarker market’, published by MarketsandMarkets (www.marketsandmarkets.com), The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report analyzes the oncology biomarkers diagnostics and discovery market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the oncology biomarkers market.

Browse more than 45 market data tables and in-depth TOC on Global Oncology Biomarkers Market.
Early buyers will receive 10% customization of reports.
http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.
Market players are now focusing on new product and consolidations to enhance their commercial portfolios. The most common strategies adopted by market players include agreement and collaborations to stabilize management costs and to take advantage of the core competencies of the partner company.

Scope and Format

The report analyzes the Oncology biomarkers market into the following segments:
• Oncology biomarkers discovery market
• Oncology biomarkers diagnostics market
The market data consists of aggregate sales figures of all oncology biomarkers submarkets. It analyzes the market aspects of products and services; sourcing key market developments from the top companies that it profiles.

Analyst Briefing Presentation on the Global Oncology Biomarkers Market to Be Held On 18th May 2010

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global oncology biomarkers market to be held on 18th May 2010. The briefing on the Global Oncology Biomarkers market (2009-2014) will benefit the biomarker technology providers, biopharma associations and forums and pharmaceutical companies.

Table of Contents

Executive summary
Market overview
Market dynamics
Oncology Biomarkers diagnostics Market
Oncology Biomarkers discovery Market
Geographical analysis
competitive landscape
1. Introduction
1.1 KEY TAKE-AWAYS
1.2 Report description
1.3 MarketS COVERED
1.4 Research Methodology
1.5 Stakeholders
2. Summary
3. Market overview
3.1 Introduction
3.2 Defining the Market
3.3 classification of Cancer Biomarkers
3.4 Factors influencing Market growth
3.5 Market share Analysis
3.5.1 BY Market segment
3.5.2 By Market player
3.6 Patent analysis
4. Market dynamics
4.1 Introduction
4.2 Drivers
4.2.1 enhanced accuracy & speed of diagnosis
4.2.2 Streamlined drug delivery process
4.2.3 increased survival rates
4.2.4 non-invasive diagnosis
4.2.5 U.S. Government initiatives
4.2.6 fewer FDA approvals for cancer drugs
4.2.7 Demographic & OTHER factors
4.3 Restraints
4.3.1 High cost & complexity of Biomarker validation
4.3.2 Reimbursement issues
4.3.3 Other validation issues
4.3.4 need for Immediate processing
5. Oncology Biomarkers Diagnostics Market
5.1 INTRODUCTION
5.2 Immunoassays
5.3 Immunohistochemical (IHC) TESTS
5.4 Molecular (DNA and genomic) diagnostic assays
5.5 genetic and Genomic markers
5.6 Proteomics
5.7 Flow cytometry
5.8 Stem cell markers
5.9 Monoclonal antibodies
5.10 Pharmacogenomics
5.11 DNA Microarrays
5.12 Ivd multivariate index assays (IVDMIA)
6. Oncology Biomarkers Discovery Market
6.1 Metabolomics
6.2 Genetic Methods
6.2.1 DNA arrays
6.2.2 Southern Blot
6.2.3 Polymerase Chain Reaction (PCR)
6.2.4 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
6.2.5 Fluorescent In Situ Hybridization (FISH)
6.3 Protein Methods
6.3.1 Immunohistochemistry (IHC)
6.3.2 Mass Spectrometry (MS)
6.4 Imaging
6.4.1 Positron Emission Tomography (PET)
6.4.2 Computed Tomography (CT)
6.4.3 Magnetic Resonance Imaging (MRI)
6.4.4 Magnetic Resonance Spectroscopy (MRS)
6.4.5 Single-Photon Emission Computed Tomography (SPECT)
6.4.6 X-ray
6.4.7 Biophotonics
6.4.8 Ultrasound
7. Geographical analysis
7.1 North America
7.2 Europe
7.3 Asia
7.4 ROW
8. competitive landscape
9. Company Profiles
9.1 Abbott Laboratories
9.2 Affymetrix, Inc
9.3 Agendia Bv
9.4 Ambrilia Biopharma
9.5 Astellas Pharma US Inc
9.6 Aureon Laboratories, Inc
9.7 Beckman Coulter, Inc
9.8 Becton, Dickinson and Company
9.9 BioCurex Inc
9.10 Biomerieux S.A.
9.11 Biomoda, Inc
9.12 Clarient, Inc
9.13 Correlogic Systems, Inc
9.14 Diadexus, Inc
9.15 DiagnoCure Inc
9.16 Epigenomics AG
9.17 EUSA Pharma (USA) Inc
9.18 Exact Sciences Corp
9.19 Fujirebio Diagnostics, Inc
9.20 Gen-Probe, Inc
9.21 Genomic Health Inc
9.22 Geron Corp
9.23 Hologic Inc
9.24 Immunomedics, Inc
9.25 Inverness Medical Innovations, Inc
9.26 Laboratory Corp. of America Holdings
9.27 Morphotek, Inc
9.28 Myriad Genetics, Inc
9.29 Northwest Biotherapeutics Inc
9.30 Ocimum Biosolutions Ltd
9.31 Oncothyreon, Inc
9.32 Polymedco Inc
9.33 Poniard Pharmaceuticals Inc
9.34 Qiagen N.V.
9.35 Radient Pharmaceuticals Corp
9.36 Siemens Healthcare
9.37 Veridex LLC
Appendix
U.S. Patets
Europe Patents
Japan Patents

To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/oncology-biomarker-market.asp

Related Reports

http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html
http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html
http://www.marketsandmarkets.com/Market-Reports/dermatology-market-154.html

About us
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
Sunita
7557 Rambler road, Suite 727, Dallas, TX 75231
Dallas TX, 75231

1-888-989-8004